FOXN3 and central nervous system cancer: Kaplan-Meier survival curve manifested that glioma patients with low FOXN3 expression (n = 32) exhibited a shorter overall survival time than those with high FOXN3 expression (n = 31; Figure 1C, P < 0.05).